LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response.

    Oskvig, Devon B / Elkahloun, Abdel G / Johnson, Kory R / Phillips, Terry M / Herkenham, Miles

    Brain, behavior, and immunity

    2012  Volume 26, Issue 4, Page(s) 623–634

    Abstract: Maternal immune activation (MIA) is a risk factor for the development of schizophrenia and autism. Infections during pregnancy activate the mother's immune system and alter the fetal environment, with consequential effects on CNS function and behavior in ...

    Abstract Maternal immune activation (MIA) is a risk factor for the development of schizophrenia and autism. Infections during pregnancy activate the mother's immune system and alter the fetal environment, with consequential effects on CNS function and behavior in the offspring, but the cellular and molecular links between infection-induced altered fetal development and risk for neuropsychiatric disorders are unknown. We investigated the immunological, molecular, and behavioral effects of MIA in the offspring of pregnant Sprague-Dawley rats given an intraperitoneal (0.25 mg/kg) injection of lipopolysaccharide (LPS) on gestational day 15. LPS significantly elevated pro-inflammatory cytokine levels in maternal serum, amniotic fluid, and fetal brain at 4 h, and levels decreased but remained elevated at 24 h. Offspring born to LPS-treated dams exhibited reduced social preference and exploration behaviors as juveniles and young adults. Whole genome microarray analysis of the fetal brain at 4 h post maternal LPS was performed to elucidate the possible molecular mechanisms by which MIA affects the fetal brain. We observed dysregulation of 3285 genes in restricted functional categories, with increased mRNA expression of cellular stress and cell death genes and reduced expression of developmentally-regulated and brain-specific genes, specifically those that regulate neuronal migration of GABAergic interneurons, including the Distal-less (Dlx) family of transcription factors required for tangential migration from progenitor pools within the ganglionic eminences into the cerebral cortex. Our results provide a novel mechanism by which MIA induces the widespread down-regulation of critical neurodevelopmental genes, including those previously associated with autism.
    MeSH term(s) Amniotic Fluid/immunology ; Animals ; Autistic Disorder/immunology ; Brain/embryology ; Brain/immunology ; Cell Movement/immunology ; Cytokines/analysis ; Down-Regulation/immunology ; Exploratory Behavior ; Female ; Fetus/embryology ; Fetus/immunology ; Gene Expression Profiling ; Interneurons/immunology ; Lipopolysaccharides/administration & dosage ; Lipopolysaccharides/immunology ; Oxidative Stress ; Pregnancy ; Pregnancy Complications, Infectious/immunology ; Prenatal Exposure Delayed Effects/immunology ; RNA, Messenger/metabolism ; Rats ; Rats, Sprague-Dawley ; Social Behavior ; Transcription Factors/metabolism
    Chemical Substances Cytokines ; Lipopolysaccharides ; RNA, Messenger ; Transcription Factors
    Language English
    Publishing date 2012-01-30
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 639219-2
    ISSN 1090-2139 ; 0889-1591
    ISSN (online) 1090-2139
    ISSN 0889-1591
    DOI 10.1016/j.bbi.2012.01.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

    Diaz-Arrastia, Ramon / Kochanek, Patrick M / Bergold, Peter / Kenney, Kimbra / Marx, Christine E / Grimes, Col Jamie B / Loh, L T C Yince / Adam, L T C Gina E / Oskvig, Devon / Curley, Kenneth C / Salzer, Wanda

    Journal of neurotrauma

    2013  Volume 31, Issue 2, Page(s) 135–158

    Abstract: ... of the science and ongoing research and (b) identified research gaps to inform future development of research ...

    Abstract Despite substantial investments by government, philanthropic, and commercial sources over the past several decades, traumatic brain injury (TBI) remains an unmet medical need and a major source of disability and mortality in both developed and developing societies. The U.S. Department of Defense neurotrauma research portfolio contains more than 500 research projects funded at more than $700 million and is aimed at developing interventions that mitigate the effects of trauma to the nervous system and lead to improved quality of life outcomes. A key area of this portfolio focuses on the need for effective pharmacological approaches for treating patients with TBI and its associated symptoms. The Neurotrauma Pharmacology Workgroup was established by the U.S. Army Medical Research and Materiel Command (USAMRMC) with the overarching goal of providing a strategic research plan for developing pharmacological treatments that improve clinical outcomes after TBI. To inform this plan, the Workgroup (a) assessed the current state of the science and ongoing research and (b) identified research gaps to inform future development of research priorities for the neurotrauma research portfolio. The Workgroup identified the six most critical research priority areas in the field of pharmacological treatment for persons with TBI. The priority areas represent parallel efforts needed to advance clinical care; each requires independent effort and sufficient investment. These priority areas will help the USAMRMC and other funding agencies strategically guide their research portfolios to ensure the development of effective pharmacological approaches for treating patients with TBI.
    MeSH term(s) Biomedical Research/standards ; Biomedical Research/trends ; Brain Injuries/drug therapy ; Humans ; Neuropharmacology/standards ; Neuropharmacology/trends ; United States ; United States Department of Defense/standards ; United States Department of Defense/trends
    Language English
    Publishing date 2013-08-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 645092-1
    ISSN 1557-9042 ; 0897-7151
    ISSN (online) 1557-9042
    ISSN 0897-7151
    DOI 10.1089/neu.2013.3019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top